 |
|
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials
Matthew Rashid, Eli Oldham, Griffin K. Hughes, Andriana M. Peña, Chase Ladd, Brooke Gardner, Ryan McIntire, Bradley Johnson, Jordan Tuia, Alyson Haslam, Vinay Prasad, Matt Vassar
J Urol Oncol. 2024;22(3):211-223. Published online 2024 Nov 30 DOI: https://doi.org/10.22465/juo.244800520026
|
|
Citations to this article as recorded by
 Editorial for JUO 2024 Vol. 22 No. 3 - Rethinking Urologic Oncology Surgery
Cheol Kwak
Journal of Urologic Oncology.2024; 22(3): 185. CrossRef
|